feed rss
Star Alliance


IWG (Immunonephrology Working Group)


11.30 - 13.00

Treatment of Lupus Nephritis

Chairs: David Jayne, Cambridge, UK
            Vladimir Tesar, Prague, Czech Republic

- Rituximab (in the treatment of lupus nephritis): do the benefits outweight the risks?
Vladimir Tesar, Prague, Czech Republic

- Rituximab associated with mycophenolate: the LUNAR trial experience
Fernando Fervenza, Rochester, USA

- Update on biologic and stem cell therapies for lupus nephritis
David Jayne, Cambridge, UK

- The role of repeated biopsies in the management of Lupus Nephritis
Franco Ferrario, Milan, Italy

In order to participate in the CME Courses held on May 18, 2013, all regularly registered congress members must go to the session halls and have their badge scanned by the hostesses at the entrance (at participant’s own responsibility). Please note that the seat capacity of the conference rooms is limited, therefore participation in these courses will be on a “first come first served” basis. The courses are reserved to regularly registered congress members and are included in the registration fee.

back to the timetable

final programme "day by day" - may 18 - 21, 2013